Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

己酮可可碱缓释片 - NMPA Drug Approval Details

Approvals/NMPA/Pentoxifylline Sustained-release Tablets

Approved

化学药品

Pentoxifylline Sustained-release Tablets

本溪匠成医药科技有限公司🇨🇳 National Medical Products Administration

Approval Date: Mar 3, 2026
Approval ID: 8mfjjLR7UIW
Company: 本溪匠成医药科技有限公司
Type: 化学药品

Approval Details

Approval Id: 8mfjjLR7UIW
Approval Number: 国药准字H20263516
Generic Name: 己酮可可碱缓释片
Generic Name En: Pentoxifylline Sustained-release Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 0.4g
Reg Date: 2026-03-03
Company Name: 本溪匠成医药科技有限公司
Company Address: 辽宁省本溪市经济技术开发区神农大街28-7栋1门
Production Company Name: 吉林四环制药有限公司
Production Company Address: 吉林省梅河口市梧桐路2588号
Company Detail Path: /organization/e685fd65365f1a83/ben-xi-jiang-cheng-yi-yao-ke-ji-you-xian-gong-si
Production Company Detail Path: /organization/73647e915f5204fb/ji-lin-si-huan-zhi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 3, 2026

Approval ID

8mfjjLR7UIW

Type

化学药品

Back to NMPA Approvals